×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Ocular Therapeutix Inc. (OCUL) NASDAQ

$9.10 (0.21) (-2.26%)

Market Cap: $1.38B

As of 03/28/24 04:00 PM EDT. Market closed.

(OCUL)

Ocular Therapeutix Inc. (OCUL)
NASDAQ

$9.10
(0.21) (-2.26%)

Market Cap: $1.38B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

ocular therapeutix, inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology. ocular therapeutix’s lead product candidate, dextenza™ (dexamethasone insert) 0.4 mg for intracanalicular use, has completed phase 3 clinical ... read more

ocular therapeutix, inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology. ocular therapeutix’s lead product candidate, dextenza™ (dexamethasone insert) 0.4 mg for intracanalicular use, has completed phase 3 clinical development for the treatment of ocular pain and inflammation following ophthalmic surgery. otx-tp (travoprost insert) is in phase 3 clinical development for the reduction of intraocular pressure in patients with glaucoma and ocular hypertension. the company’s earlier stage assets include otx-tic, a sustained release travoprost intracameral injection for the reduction in intraocular pressure in patients with glaucoma and ocular hypertension, as well as sustained release intravitreal injections for the treatment of retinal diseases. these injections include the development of otx-tki, a tyrosine kinase inhib read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Antony Mattessich
Full Time Employees
274
CEO Compensation (Base)
$564,850
CEO Compensation (Total)
$2.63M
URL
Address
24 Crosby Dr, Massachusetts, Bedford, 01730-1402.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Antony Mattessich
Full Time Employees
274
CEO Compensation (Base)
$564,850
CEO Compensation (Total)
$2.63M
Address
24 Crosby Dr, Massachusetts, Bedford, 01730-1402.
PRICE CHART FOR OCULAR THERAPEUTIX INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.29
Previous Close
$9.31
Days Range
$9.13 - $9.54
52 week range
$2 - $11.31
Volume
2,199,081
Avg. Volume (30 days)
2,527,160
Market Cap
$1.38B
Dividend Yield
-
P/E
(17.14)
Shares Outstanding
148,627,439
Open
$9.29
Previous Close
$9.31
Days Range
$9.13 - $9.54
52 week range
$2 - $11.31
Volume
2,199,081
Avg. Volume (30 days)
2,527,160
Market Cap
$1.38B
Dividend Yield
-
P/E
(17.14)
Shares Outstanding
148,627,439
FINANCIAL STATEMENTS FOR OCULAR THERAPEUTIX INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR OCULAR THERAPEUTIX INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
SUMMER ROAD LLC10% OwnerFeb 26, 2024 Buy$7.52930,8517,000,0008,591,401Feb 27, 2024, 04:43 PM
White Christopher GChief Business OfficerFeb 05, 2024 Sale$4.865,91028,723123,689Feb 06, 2024, 06:38 PM
Strassburger Philip C.General CounselFeb 05, 2024 Sale$4.866,02929,301161,493Feb 06, 2024, 06:35 PM
Ozden Rabia GursesChief Medical OfficerFeb 05, 2024 Sale$4.866,34630,842153,054Feb 06, 2024, 06:32 PM
Notman DonaldChief Financial OfficerFeb 05, 2024 Sale$4.866,21230,190195,356Feb 06, 2024, 06:29 PM
Mattessich Antony C.President and CEOFeb 05, 2024 Sale$4.8619,64295,460588,701Feb 06, 2024, 06:26 PM
Notman DonaldChief Financial OfficerJan 31, 2024 Sale$4.956,43331,843139,932Feb 02, 2024, 07:03 PM
Ozden Rabia GursesChief Medical OfficerJan 31, 2024 Sale$4.957,76438,43292,767Feb 02, 2024, 07:02 PM
Strassburger Philip C.General CounselJan 31, 2024 Sale$4.956,83133,813109,218Feb 02, 2024, 07:01 PM
White Christopher GChief Business OfficerJan 31, 2024 Sale$4.955,14725,47889,619Feb 02, 2024, 07:01 PM
Mattessich Antony C.President and CEOJan 31, 2024 Sale$4.9518,33890,773427,943Feb 02, 2024, 07:00 PM
SUMMER ROAD LLC10% OwnerDec 14, 2023 Buy$3.251,538,4614,999,9987,660,550Dec 18, 2023, 04:52 PM
Mattessich Antony C.President and CEOAug 30, 2023 Buy$3.816,50024,7656,500Sep 05, 2023, 08:27 AM
Ozden Rabia GursesChief Medical OfficerJul 07, 2023 Sale$4.938324,102100,531Jul 11, 2023, 08:00 PM
White Christopher GChief Business OfficerFeb 06, 2023 Sale$4.245,82924,71594,766Feb 08, 2023, 07:38 PM
Ozden Rabia GursesChief Medical OfficerFeb 06, 2023 Sale$4.246,41627,204101,363Feb 08, 2023, 07:33 PM
Notman DonaldChief Financial OfficerFeb 06, 2023 Sale$4.246,47627,458139,387Feb 08, 2023, 07:32 PM
Strassburger Philip C.General CounselFeb 06, 2023 Sale$4.246,18126,207109,071Feb 08, 2023, 07:31 PM
Mattessich Antony C.President and CEOFeb 06, 2023 Sale$4.2419,66983,397446,281Feb 08, 2023, 07:29 PM
SUMMER ROAD LLC10% OwnerNov 07, 2022 Buy$3.507,32825,6486,122,089Nov 09, 2022, 04:48 PM
SUMMER ROAD LLC10% OwnerOct 11, 2022 Buy$3.9010,00038,9936,114,761Oct 12, 2022, 04:34 PM
SUMMER ROAD LLC10% OwnerOct 10, 2022 Buy$4.0010,00039,9826,104,761Oct 12, 2022, 04:34 PM
SUMMER ROAD LLC10% OwnerSep 27, 2022 Buy$4.68130,000608,3226,074,761Sep 29, 2022, 07:51 PM
SUMMER ROAD LLC10% OwnerSep 29, 2022 Buy$4.0418,80075,9886,094,761Sep 29, 2022, 07:51 PM
SUMMER ROAD LLC10% OwnerSep 28, 2022 Buy$4.101,2004,9206,075,961Sep 29, 2022, 07:51 PM
LINDSTROM RICHARD L MDDirectorMay 12, 2022 Option Exercise$1.229,46911,55299,469May 16, 2022, 04:13 PM
Heier Jeffrey S.DirectorMay 12, 2022 Buy$3.0515,00045,75039,000May 16, 2022, 04:10 PM
SUMMER ROAD LLC10% OwnerFeb 23, 2022 Buy$4.8010,00047,9865,944,761Feb 23, 2022, 05:08 PM
SUMMER ROAD LLC10% OwnerFeb 18, 2022 Buy$5.0040,000199,9405,934,761Feb 23, 2022, 05:08 PM
SUMMER ROAD LLC10% OwnerJan 28, 2022 Buy$5.204,02320,9205,894,761Jan 31, 2022, 07:00 PM
SUMMER ROAD LLC10% OwnerJan 27, 2022 Buy$5.201,4777,6805,890,738Jan 31, 2022, 07:00 PM
SUMMER ROAD LLC10% OwnerJan 24, 2022 Buy$5.3144,400235,8935,889,261Jan 24, 2022, 05:19 PM
SUMMER ROAD LLC10% OwnerJan 21, 2022 Buy$5.5612,15267,5315,844,861Jan 24, 2022, 05:19 PM
SUMMER ROAD LLC10% OwnerJan 20, 2022 Buy$5.7017,948102,3845,832,709Jan 24, 2022, 05:19 PM
SUMMER ROAD LLC10% OwnerJan 18, 2022 Buy$6.006,80740,8275,814,761Jan 18, 2022, 05:30 PM
SUMMER ROAD LLC10% OwnerJan 14, 2022 Buy$6.0333,193200,1115,807,954Jan 18, 2022, 05:30 PM
SUMMER ROAD LLC10% OwnerJan 13, 2022 Buy$6.2010,00061,9835,774,761Jan 18, 2022, 05:30 PM
SUMMER ROAD LLC10% OwnerDec 15, 2021 Buy$6.2215,00093,2465,764,761Dec 16, 2021, 05:05 PM
SUMMER ROAD LLC10% OwnerDec 14, 2021 Buy$6.4129,490189,1755,749,761Dec 16, 2021, 05:05 PM
SUMMER ROAD LLC10% OwnerDec 13, 2021 Buy$6.5010,51068,3025,720,271Dec 14, 2021, 07:28 PM
SUMMER ROAD LLC10% OwnerDec 10, 2021 Buy$6.6530,000199,4945,709,761Dec 14, 2021, 07:28 PM
SUMMER ROAD LLC10% OwnerDec 08, 2021 Buy$6.755,30035,7755,679,761Dec 08, 2021, 06:05 PM
SUMMER ROAD LLC10% OwnerDec 06, 2021 Buy$6.1355,600340,8285,674,461Dec 08, 2021, 06:05 PM
Mattessich Antony C.President and CEOAug 20, 2021 Buy$9.895,00049,450102,900Aug 24, 2021, 08:49 AM
PEACOCK BRUCEDirectorDec 03, 2020 Option Exercise$5.0925,000127,18025,000Dec 07, 2020, 09:30 PM
SUMMER ROAD LLC10% OwnerOct 16, 2020 Buy$10.484374,5805,618,861Oct 20, 2020, 04:06 PM
SUMMER ROAD LLC10% OwnerMay 19, 2020 Buy$5.50363,6361,999,9985,618,424May 21, 2020, 04:15 PM
SUMMER ROAD LLC10% OwnerMar 24, 2020 Buy$4.8735,052170,7145,254,788Mar 24, 2020, 09:42 PM
SUMMER ROAD LLC10% OwnerMar 23, 2020 Buy$4.6664,948302,3655,219,736Mar 24, 2020, 09:42 PM
SUMMER ROAD LLC10% OwnerMar 20, 2020 Buy$4.529,10041,1195,154,788Mar 24, 2020, 09:42 PM
SUMMER ROAD LLC10% OwnerMar 18, 2020 Buy$4.62344,9381,594,2005,104,788Mar 20, 2020, 09:34 PM
SUMMER ROAD LLC10% OwnerMar 19, 2020 Buy$4.6340,900189,2245,145,688Mar 20, 2020, 09:34 PM
SUMMER ROAD LLC10% OwnerMar 17, 2020 Buy$4.66550,0002,562,8904,759,850Mar 17, 2020, 09:35 PM
SUMMER ROAD LLC10% OwnerMar 16, 2020 Buy$4.16194,262807,2174,209,850Mar 17, 2020, 09:35 PM
SUMMER ROAD LLC10% OwnerMar 13, 2020 Buy$4.63210,800975,9834,015,588Mar 17, 2020, 09:35 PM
Opaleye Management Inc.10% OwnerJan 02, 2020 Buy$3.9015,00058,5084,918,500Jan 03, 2020, 07:45 PM
Opaleye Management Inc.10% OwnerDec 30, 2019 Buy$3.9715,00059,5574,903,500Jan 02, 2020, 05:15 PM
Opaleye Management Inc.10% OwnerDec 30, 2019 Buy$3.975,00019,852207,500Jan 02, 2020, 05:15 PM
Notman DonaldChief Financial OfficerJun 14, 2019 Buy$4.332,50010,82524,049Jun 17, 2019, 07:21 PM
Williams Leslie J.DirectorJun 14, 2019 Buy$4.404,50019,8004,500Jun 17, 2019, 07:21 PM
Sawhney AmarpreetChairman of the BoardJun 07, 2019 Buy$3.0265,468197,7131,056,031Jun 10, 2019, 04:55 PM
Sawhney AmarpreetChairman of the BoardJun 06, 2019 Buy$2.8059,000165,200990,563Jun 10, 2019, 04:55 PM
Mattessich Antony C.President & CEOJun 06, 2019 Buy$2.8140,000112,40097,900Jun 10, 2019, 04:53 PM
Sawhney AmarpreetChairman of the BoardJun 04, 2019 Buy$2.9212,92837,750898,711Jun 06, 2019, 06:09 PM
Sawhney AmarpreetChairman of the BoardJun 05, 2019 Buy$2.9132,85295,599931,563Jun 06, 2019, 06:09 PM
Goldstein Michael H.Chief Medical OfficerMay 28, 2019 Buy$2.5112,00030,12025,686May 30, 2019, 04:10 PM
Heier Jeffrey S.DirectorMar 15, 2019 Buy$4.1524,00099,60024,000Mar 18, 2019, 06:20 PM
Goldstein Michael H.Chief Medical OfficerMar 15, 2019 Buy$4.1510,00041,50013,686Mar 18, 2019, 06:20 PM
LINDSTROM RICHARD L MDDirectorMar 13, 2019 Buy$4.3356,441244,390100,000Mar 14, 2019, 04:14 PM
Hanley Kevin F.See RemarksDec 14, 2018 Buy$5.5010,00055,00020,000Dec 18, 2018, 08:52 AM
Hanley Kevin F.SEE REMARKSDec 10, 2018 Buy$5.6010,00056,00010,000Dec 12, 2018, 04:35 PM
Bollag Daniel MSee RemarksDec 06, 2018 Buy$5.7617,400100,22442,100Dec 10, 2018, 04:15 PM
Mattessich Antony C.President & CEOAug 20, 2018 Buy$5.9520,000119,00057,900Aug 21, 2018, 04:30 PM
Notman DonaldChief Financial OfficerAug 14, 2018 Buy$6.2912,50078,62517,300Aug 15, 2018, 05:13 PM
Mattessich Antony C.President and CEOAug 10, 2018 Buy$6.2316,900105,28737,900Aug 13, 2018, 04:43 PM
Sawhney AmarpreetExec Chairman of the BoardDec 21, 2017 Option Exercise$2.62189,393497,120885,783Dec 22, 2017, 04:37 PM
Mattessich Antony C.President and C.E.O.Dec 12, 2017 Buy$4.2921,00090,09021,000Dec 13, 2017, 05:15 PM
Notman DonaldChief Financial OfficerDec 07, 2017 Buy$4.004,80019,2004,800Dec 08, 2017, 04:27 PM
Bollag Daniel MSee RemarksDec 06, 2017 Buy$3.9324,70097,07124,700Dec 08, 2017, 04:26 PM
Sawhney AmarpreetExec. Chairman of the BoardNov 16, 2017 Buy$5.1819,00098,420696,390Nov 20, 2017, 08:04 AM
Sawhney AmarpreetPresident and CEODec 15, 2016 Buy$7.8545,300355,605677,390Dec 16, 2016, 04:04 PM
Sawhney AmarpreetPresident and CEOAug 05, 2016 Option Exercise$1.3558,35778,782632,090Aug 09, 2016, 04:38 PM
Sawhney AmarpreetPresident and CEOJun 09, 2016 Buy$6.7010,00067,000573,733Jun 10, 2016, 04:30 PM
Sawhney AmarpreetPresident and CEONov 17, 2015 Buy$8.2510,00082,500563,733Nov 18, 2015, 08:24 PM
Fortune JamesChief Operating OfficerSep 15, 2015 Sale$17.169,470162,505112,060Sep 17, 2015, 04:05 PM
Sawhney AmarpreetPresident and CEOSep 14, 2015 Buy$16.5015,000247,456553,733Sep 16, 2015, 04:06 PM
Versant Venture Capital III, L.P.10% OwnerJun 15, 2015 Sale$22.001,87841,31613,007Jun 15, 2015, 05:51 PM
Versant Venture Capital III, L.P.10% OwnerJun 15, 2015 Sale$22.00318,1226,998,6842,202,377Jun 15, 2015, 05:51 PM
Warden Charles MDirectorJun 15, 2015 Sale$22.00320,0007,040,0002,202,377Jun 15, 2015, 05:45 PM
SVLSF IV, LLC10% OwnerJun 10, 2015 Sale$22.00746,00016,412,0002,212,607Jun 11, 2015, 05:29 PM
SVLSF IV, LLC10% OwnerJun 10, 2015 Sale$22.00373,0008,206,0002,151,523Jun 11, 2015, 05:29 PM
Warden Charles MDirectorJun 10, 2015 Sale$22.00427,0009,394,0002,520,499Jun 11, 2015, 05:24 PM
Versant Venture Capital III, L.P.10% OwnerJun 10, 2015 Sale$22.002,50655,13214,885Jun 11, 2015, 05:24 PM
Versant Venture Capital III, L.P.10% OwnerJun 10, 2015 Sale$22.00424,4949,338,8682,520,499Jun 11, 2015, 05:24 PM
Sawhney AmarpreetPresident and CEOMay 13, 2015 Option Exercise$1.3551,49169,513538,733May 15, 2015, 04:09 PM
LINDSTROM RICHARD L MDDirectorFeb 27, 2015 Option Exercise$0.3324,6208,10543,559Apr 01, 2015, 06:10 PM
Ankerud EricSee RemarksJul 30, 2014 Buy$13.001,00013,00078,651Mar 06, 2015, 06:56 PM
Polaris Venture Management Co. V, L.L.C.10% OwnerFeb 02, 2015 Sale$29.50500,00014,750,0001,958,824Feb 04, 2015, 04:30 PM
CHV II, L.P.10% OwnerJul 30, 2014 Buy$13.00153,8461,999,9982,100,138Aug 08, 2014, 05:03 PM
Sawhney AmarpreetPresident and CEOJul 30, 2014 Buy$13.0076,922999,986471,784Jul 31, 2014, 05:33 PM
SVLSF IV, LLC10% OwnerJul 30, 2014 Buy$13.00238,4603,099,9802,514,226Jul 31, 2014, 04:14 PM
SVLSF IV, LLC10% OwnerJul 30, 2014 Buy$13.00476,9206,199,9602,585,607Jul 31, 2014, 04:14 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
SUMMER ROAD LLC10% Owner02/26/20247,000,000
White Christopher GChief Business Officer02/05/202428,723
Strassburger Philip C.General Counsel02/05/202429,301
Ozden Rabia GursesChief Medical Officer02/05/202430,842
Notman DonaldChief Financial Officer02/05/202430,190
Mattessich Antony C.President and CEO02/05/202495,460
Notman DonaldChief Financial Officer01/31/202431,843
Ozden Rabia GursesChief Medical Officer01/31/202438,432
Strassburger Philip C.General Counsel01/31/202433,813
White Christopher GChief Business Officer01/31/202425,478
Mattessich Antony C.President and CEO01/31/202490,773
SUMMER ROAD LLC10% Owner12/14/20234,999,998
Mattessich Antony C.President and CEO08/30/202324,765
Ozden Rabia GursesChief Medical Officer07/07/20234,102
White Christopher GChief Business Officer02/06/202324,715
Ozden Rabia GursesChief Medical Officer02/06/202327,204
Notman DonaldChief Financial Officer02/06/202327,458
Strassburger Philip C.General Counsel02/06/202326,207
Mattessich Antony C.President and CEO02/06/202383,397
SUMMER ROAD LLC10% Owner11/07/202225,648
SUMMER ROAD LLC10% Owner10/11/202238,993
SUMMER ROAD LLC10% Owner10/10/202239,982
SUMMER ROAD LLC10% Owner09/27/2022608,322
SUMMER ROAD LLC10% Owner09/29/202275,988
SUMMER ROAD LLC10% Owner09/28/20224,920
LINDSTROM RICHARD L MDDirector05/12/202211,552
Heier Jeffrey S.Director05/12/202245,750
SUMMER ROAD LLC10% Owner02/23/202247,986
SUMMER ROAD LLC10% Owner02/18/2022199,940
SUMMER ROAD LLC10% Owner01/28/202220,920
SUMMER ROAD LLC10% Owner01/27/20227,680
SUMMER ROAD LLC10% Owner01/24/2022235,893
SUMMER ROAD LLC10% Owner01/21/202267,531
SUMMER ROAD LLC10% Owner01/20/2022102,384
SUMMER ROAD LLC10% Owner01/18/202240,827
SUMMER ROAD LLC10% Owner01/14/2022200,111
SUMMER ROAD LLC10% Owner01/13/202261,983
SUMMER ROAD LLC10% Owner12/15/202193,246
SUMMER ROAD LLC10% Owner12/14/2021189,175
SUMMER ROAD LLC10% Owner12/13/202168,302
SUMMER ROAD LLC10% Owner12/10/2021199,494
SUMMER ROAD LLC10% Owner12/08/202135,775
SUMMER ROAD LLC10% Owner12/06/2021340,828
Mattessich Antony C.President and CEO08/20/202149,450
PEACOCK BRUCEDirector12/03/2020127,180
SUMMER ROAD LLC10% Owner10/16/20204,580
SUMMER ROAD LLC10% Owner05/19/20201,999,998
SUMMER ROAD LLC10% Owner03/24/2020170,714
SUMMER ROAD LLC10% Owner03/23/2020302,365
SUMMER ROAD LLC10% Owner03/20/202041,119
SUMMER ROAD LLC10% Owner03/18/20201,594,200
SUMMER ROAD LLC10% Owner03/19/2020189,224
SUMMER ROAD LLC10% Owner03/17/20202,562,890
SUMMER ROAD LLC10% Owner03/16/2020807,217
SUMMER ROAD LLC10% Owner03/13/2020975,983
Opaleye Management Inc.10% Owner01/02/202058,508
Opaleye Management Inc.10% Owner12/30/201959,557
Opaleye Management Inc.10% Owner12/30/201919,852
Notman DonaldChief Financial Officer06/14/201910,825
Williams Leslie J.Director06/14/201919,800
Sawhney AmarpreetChairman of the Board06/07/2019197,713
Sawhney AmarpreetChairman of the Board06/06/2019165,200
Mattessich Antony C.President & CEO06/06/2019112,400
Sawhney AmarpreetChairman of the Board06/04/201937,750
Sawhney AmarpreetChairman of the Board06/05/201995,599
Goldstein Michael H.Chief Medical Officer05/28/201930,120
Heier Jeffrey S.Director03/15/201999,600
Goldstein Michael H.Chief Medical Officer03/15/201941,500
LINDSTROM RICHARD L MDDirector03/13/2019244,390
Hanley Kevin F.See Remarks12/14/201855,000
Hanley Kevin F.SEE REMARKS12/10/201856,000
Bollag Daniel MSee Remarks12/06/2018100,224
Mattessich Antony C.President & CEO08/20/2018119,000
Notman DonaldChief Financial Officer08/14/201878,625
Mattessich Antony C.President and CEO08/10/2018105,287
Sawhney AmarpreetExec Chairman of the Board12/21/2017497,120
Mattessich Antony C.President and C.E.O.12/12/201790,090
Notman DonaldChief Financial Officer12/07/201719,200
Bollag Daniel MSee Remarks12/06/201797,071
Sawhney AmarpreetExec. Chairman of the Board11/16/201798,420
Sawhney AmarpreetPresident and CEO12/15/2016355,605
Sawhney AmarpreetPresident and CEO08/05/201678,782
Sawhney AmarpreetPresident and CEO06/09/201667,000
Sawhney AmarpreetPresident and CEO11/17/201582,500
Fortune JamesChief Operating Officer09/15/2015162,505
Sawhney AmarpreetPresident and CEO09/14/2015247,456
Versant Venture Capital III, L.P.10% Owner06/15/201541,316
Versant Venture Capital III, L.P.10% Owner06/15/20156,998,684
Warden Charles MDirector06/15/20157,040,000
SVLSF IV, LLC10% Owner06/10/201516,412,000
SVLSF IV, LLC10% Owner06/10/20158,206,000
Warden Charles MDirector06/10/20159,394,000
Versant Venture Capital III, L.P.10% Owner06/10/201555,132
Versant Venture Capital III, L.P.10% Owner06/10/20159,338,868
Sawhney AmarpreetPresident and CEO05/13/201569,513
LINDSTROM RICHARD L MDDirector02/27/20158,105
Ankerud EricSee Remarks07/30/201413,000
Polaris Venture Management Co. V, L.L.C.10% Owner02/02/201514,750,000
CHV II, L.P.10% Owner07/30/20141,999,998
Sawhney AmarpreetPresident and CEO07/30/2014999,986
SVLSF IV, LLC10% Owner07/30/20143,099,980
SVLSF IV, LLC10% Owner07/30/20146,199,960
Load More Insider Transactions
FUNDS WITH A POSITION IN OCULAR THERAPEUTIX INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.5,761,5330.00066%7.82%Other
GEODE CAPITAL MANAGEMENT, LLC1,736,8140.00081%6.58%Other
D. E. SHAW & CO., INC.390,8350.00152%-33.18%Other
UBS OCONNOR LLC332,0910.11%-2.93%Value
TUDOR INVESTMENT CORP ET AL138,7310.00498%-20.35%Event Driven, Other
RENAISSANCE TECHNOLOGIES LLC125,2000.00067%ExitedOther
BALYASNY ASSET MANAGEMENT L.P.89,0000.00075%70.03%Event Driven
AQR CAPITAL MANAGEMENT LLC52,2280.00044%-22.28%Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)18,9870.00156%NewOther
CHANGE IN SHARES OUTSTANDING FOR OCULAR THERAPEUTIX INC
STOCK BUYBACKS FOR OCULAR THERAPEUTIX INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
6.00%
1Q
12/31/2023
06/30/2023
15.63%
2Q
12/31/2023
03/31/2023
16.62%
3Q
12/31/2023
12/31/2022
9.02%
4Q
12/31/2023
09/30/2022
17.24%
5Q
12/31/2023
06/30/2022
9.35%
6Q
12/31/2023
03/31/2022
9.37%
7Q
12/31/2023
12/31/2021
9.54%
8Q
12/31/2023
09/30/2021
5.62%
9Q
12/31/2023
06/30/2021
9.94%
10Q
12/31/2023
03/31/2021
3.44%
11Q
12/31/2023
12/31/2020
27.68%
12Q
12/31/2023
09/30/2020
31.25%
13Q
12/31/2023
06/30/2020
57.32%
14Q
12/31/2023
03/31/2020
73.89%
15Q
12/31/2023
12/31/2019
84.43%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
6.00%
1Q
06/30/2023
15.63%
2Q
03/31/2023
16.62%
3Q
12/31/2022
9.02%
4Q
09/30/2022
17.24%
5Q
06/30/2022
9.35%
6Q
03/31/2022
9.37%
7Q
12/31/2021
9.54%
8Q
09/30/2021
5.62%
9Q
06/30/2021
9.94%
10Q
03/31/2021
3.44%
11Q
12/31/2020
27.68%
12Q
09/30/2020
31.25%
13Q
06/30/2020
57.32%
14Q
03/31/2020
73.89%
15Q
12/31/2019
84.43%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR OCULAR THERAPEUTIX INC
LOADING...